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Abstract
Background: Genome wide association studies have been hugely successful in identifying disease
risk variants, yet most variants do not lead to coding changes and how variants influence biological
function is usually unknown.
Methods: We correlated gene expression and genetic variation in untouched primary leucocytes
(n = 110) from individuals with celiac disease – a common condition with multiple risk variants
identified. We compared our observations with an EBV-transformed HapMap B cell line dataset (n
= 90), and performed a meta-analysis to increase power to detect non-tissue specific effects.
Results: In celiac peripheral blood, 2,315 SNP variants influenced gene expression at 765 different
transcripts (< 250 kb from SNP, at FDR = 0.05, cis expression quantitative trait loci, eQTLs). 135
of the detected SNP-probe effects (reflecting 51 unique probes) were also detected in a HapMap
B cell line published dataset, all with effects in the same allelic direction. Overall gene expression
differences within the two datasets predominantly explain the limited overlap in observed cis-
eQTLs. Celiac associated risk variants from two regions, containing genes IL18RAP and CCR3,
showed significant cis genotype-expression correlations in the peripheral blood but not in the B cell
line datasets. We identified 14 genes where a SNP affected the expression of different probes
within the same gene, but in opposite allelic directions. By incorporating genetic variation in co-
expression analyses, functional relationships between genes can be more significantly detected.
Conclusion: In conclusion, the complex nature of genotypic effects in human populations makes
the use of a relevant tissue, large datasets, and analysis of different exons essential to enable the
identification of the function for many genetic risk variants in common diseases.
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Human gene expression levels have a strong heritable
component [1-4]. At some genes, the variance in gene
expression levels is an order of magnitude greater between
unrelated individuals, than between identical twins [5].
Quantitative mRNA levels are key regulators of phenotype
and represent a link between genetic variation and pheno-
typic alterations. A term first introduced by Jansen & Nap
[6], genetical genomics aims to identify the genetic variants
that affect gene expression. By treating gene expression as
a quantitative trait it is possible to correlate gene transcript
expression levels with genomic locations such that expres-
sion quantitative trait loci (eQTLs) can be identified [7].
In the human genome, cis associations, where a genetic
variant affects a transcript that maps to the same locus,
have been predominantly reported [3,8]. Trans effects,
where the genetic variant is distant to the transcript loci,
are much harder to convincingly identify due to inherent
multiple testing problems. Analysis of trans effects
involves several magnitudes more statistical tests than for
cis effects. Although individual studies have reported
human trans associations, no effects have been convinc-
ingly replicated in multiple studies identified for the same
transcript and variant [1,9,10].
Quantitative transcript expression and genotype relation-
ships can be investigated via linkage or association based
methodologies. Linkage studies use a genome wide series
of markers in recombinant in-bred lines or families, to fol-
low the heritability of a trait, whilst association studies
usually compare large number of single nucleotide poly-
morphisms (SNPs) to transcript levels from unrelated
individuals. Despite its extensive use in plant [11,12],
mouse [13,14] and rat [15] models, transcript expression
and genotype correlation studies have only recently been
performed in humans [3,5,8].
Human association studies have centered on RNA
obtained from leukocytes, predominantly Epstein-Barr
virus (EBV) transformed B cell lines from HapMap indi-
viduals [3] or unrelated trios [1]. A large scale genetical
genomics linkage study has recently identified more than
1000 cis regulatory loci across the genome, in primary cry-
opreserved human leukocytes [2], although these are
broad genomic regions rather than variants in more pre-
cisely defined LD blocks. However, the former studies are
limited by their ability to assess transcripts that are signif-
icantly expressed at the point of RNA isolation. Cell
extraction methods, cryopreservation and EBV transfor-
mation all affect individual mRNA expression levels.
These variations in RNA analysis make the choice of anal-
ysis tissue of paramount importance.
Here we present an association based genetical genomics
study using primary cell RNA from peripheral blood sam-
pled from patients in remission from an immune-mediated
disease. Immediate RNA preservation during blood sam-
pling (using the PAXgene system) represents nearly in vivo
human physiological gene expression. Celiac disease is a
common (1% prevalence), inflammatory condition of the
small intestine induced by intake of gluten in wheat, rye
and barley. A strong genetic component has been estab-
lished for disease with a monozygotic concordance of 75%
[16] and 90% of cases possessing the HLA haplotype HLA-
DQ2.5 [17] and the remainder mostly have HLA-DQ8
[18]. Despite the role of the HLA, the risk of disease is still
greater in HLA matched monozygotic twins compared to
HLA matched dizygotic twins [19]. We recently performed
a genome wide association and replication study using sin-
gle nucleotide polymorphisms (SNPs) and identified an
additional eight susceptibility loci that predispose to celiac
disease [20,21]. A surprising finding from this study was
that seven of the eight regions contained promising candi-
date genes expressed in leucocytes of the immune system.
This suggested the feasibility of genetical genomics
approaches using peripheral blood to assess the biological
function of the celiac disease associated risk variants. One
goal of genetical genomics is to uncover previously
unknown biological pathways. If genetic variation affects
the expression of a gene in trans, this suggests a biological
relationship exists between the two loci. To assess this, con-
siderable amounts of effort have been devoted to the devel-
opment and application of statistical frameworks that are
capable of detecting these trans-eQTLs. However, detection
of trans-eQTLs in human populations has proven less suc-
cessful than in mouse, rat and plant recombinant inbred
lines [13,22]. It has been suggested that the extensive
genetic and environmental diversity between human indi-
viduals masks many of the existing trans-effects.
We show that numerous cis-eQTLs can be identified
through an expression analysis of peripheral blood RNA.
We also show many of these are only detectable in periph-
eral blood RNA, and not in EBV-transformed B cell lines.
Through a meta-analysis of these two datasets we identi-
fied numerous additional cis-eQTLs. We show that for
some cis-eQTLs genetic variation does not lead to overall
gene expression changes, but rather leads to shifts in the
types of different splice isoforms that are produced. The
complex nature of genotypic effects on gene expression
limits our ability to fully elucidate the effect on RNA
expression level or sequence and combined with the sig-
nificant multiple testing problems prevented the accurate
identification of trans effects.
Methods
Study population
115 UK celiac disease individuals were recruited from
Barts and the London NHS Trust and the Oxford Radcliffe
Hospitals NHS Trust after informed consent and with eth-
ical approval. Individuals all had a small bowel endo-
scopic biopsy diagnosis of celiac disease, median age of 51Page 2 of 13
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to female sex ratio of 1:3, and a median length of treat-
ment on a gluten free diet of 9.4 years (1–47). Celiac indi-
viduals responding to a gluten free diet typically show no
detectable inflammation (which we confirmed at the
mRNA level in peripheral blood). We also enrolled 22
healthy unrelated UK controls, with a male to female sex
ratio of 1:1.2, but of unknown age.
PAXgene RNA Extraction
2.5 ml of peripheral blood was collected into a PAXgene
tube (Becton Dickinson, UK, 762165). PAXgene vials
were chosen to prevent density gradient centrifugation,
immortalization or in vitro cell culture artifacts changing
mRNA profiles.
PAXgene tubes were mixed gently and incubated at room
temperature for two hours. After collection, tubes were
frozen at -20°C for at least 24 hours followed by storage
at -80°C. RNA was isolated using the PAXgene Blood RNA
isolation kit (Qiagen, UK, 762174). RNA was quantified
using the Nanodrop (Nanodrop Technologies, USA).
Total RNA integrity was analyzed using an Agilent Bioan-
alyzer (Agilent Technologies, USA).
Anti-sense RNA synthesis, amplification, purification and 
hybridization to Illumina expression chips
Anti-sense RNA was synthesized, amplified and purified
using the Ambion Illumina TotalPrep Amplification Kit
(Ambion, USA) following the manufacturers' protocol.
Complementary RNA was hybridized to Illumina
HumanRef-8 v2 Whole Genome BeadChips and scanned
on the Illumina BeadArray Reader. Data was handled
through the Illumina BeadStudio Gene Expression mod-
ule v3.2. All gene expression (MIAME compliant) and
genotype data has been made freely available by submis-
sion to GEO under GSE11501.
Quality control
Five celiac disease samples were excluded from subse-
quent analysis due to poor median probe intensity corre-
lation with all other samples or incorrect sex assignment,
based on an analysis of all the probes that mapped to the
non-pseudoautosomal region of chromosome Y. A data-
set of 110 celiac disease patients and 22 controls was then
used for analysis.
Normalization
Expression probes were mapped to the cDNA sequence from
Ensembl v45_36g [23] and the NCBI build 36 genome
assembly if necessary. Probes that had less than 96%
sequence homology or that mapped to multiple loci were
removed. Subsequent analyses were confined to autosomal
probes, in order to prevent sex specific effects on gene expres-
sion. After removal of probes that map to sex chromosomes,
data was quantile-quantile normalized [24].
Celiac disease sample genotypes
All celiac disease patients were genotyped as previously
described [20] using Illumina Infinium
HumanHap300v1.0 BeadChips.
Peripheral blood eQTL association analysis and false 
discovery rate control
257,013 autosomal SNPs were tested for association with
expression levels in the 110 celiac disease samples that
met analysis criteria of minor allele frequency (MAF) >
0.1, exact Hardy-Weinberg equilibrium P-Value > 0.0001
and call-rate > 0.95. Analyses were confined to those
probe-SNP pairs for which the distance from probe
genomic midpoint to SNP genomic location was less than
250 kb or 500 kb, depending on the analysis performed.
To prevent spurious associations due to outliers, a non-
parametric Spearman's rank correlation analysis was per-
formed. In order to correct for multiple testing we control-
led the false discovery rate (FDR) [25]. The distribution of
all the observed p-values was used to calculate the FDR, by
comparing this distribution to a null-distribution,
obtained from an identical analysis where the expression
phenotypes, relative to the genotypes had been permuted.
Through 1,000 permutations the Spearman's rank correla-
tion P-value threshold could be determined that corre-
sponded to an FDR of 0.01 or 0.05.
Validation panel: HapMap CEU samples
We compared the identified cis-eQTLs in the celiac periph-
eral blood dataset to a published human genetical genom-
ics dataset [3]. We reanalyzed expression data from EBV-
transformed B cell lines (further described as HapMap B
cell line dataset) for 90 CEU HapMap samples [3]. Analyses
were performed as described for the celiac disease samples.
To enable a comparison between the celiac peripheral
blood dataset and the HapMap B cell line dataset, only
SNPs were tested that had been successfully called within
HapMap and that were present on the Illumina
HumanHap300 platform (257,013 SNPs). Although this is
only a subset of all the SNPs that have been called for these
HapMap samples, this subset of SNPs is known to capture
most genetic Caucasian variation well [26].
Analysis of over- and underrepresented biological 
processes and function
We investigated over- or underrepresentation of certain
biological processes or functions through an analysis of
all significant cis-eQTL genes using the Panther Classifica-
tion System [27] (Binomial P-Value, Bonferroni cor-
rected).
Co-expression analysis
Many cis-eQTLs have been detected in human datasets,
but only a few trans-eQTLs have been found [1,3,8,10].
These trans-eQTLs imply a biological relationship
between the trans-locus and the trans-gene and as suchPage 3 of 13
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were to be identified, they would allow for the reconstruc-
tion of gene networks.
A different, regularly used approach for reconstructing
gene networks is by systematically assessing co-expression
between pairs of genes. We performed such a co-expres-
sion analysis for each probe that comprised a cis-eQTL
and contrasted this to an analysis where the genetic com-
ponent of the cis-eQTL on the probe intensity level had
been removed.
We first investigated whether the identified probe that
comprised a cis-eQTLs (probe distance of 250 kb, FDR of
0.05) showed co-expression with all other probes that
mapped to different chromosomes for both the celiac
peripheral blood dataset and the HapMap B cell line data-
set. We correlated the measured intensity levels with all
other probes that mapped on different chromosomes,
through a Spearman's rank correlation analysis. By apply-
ing Bonferroni correction to account for multiple testing,
sets of significantly correlated transcript-pairs could be
identified.
Subsequently we used partial-correlations, enabling us to
redo this co-expression analysis while effectively remov-
ing the genotypic effect on the probe intensity level for the
probes that constitute the significant cis-eQTLs. Again, by
applying Bonferroni correction, sets of significantly corre-
lated transcript-pairs could be identified.
Results
Celiac disease is an immune mediated disease, dominated
by TH1 cytokine response. Given the importance of tissue
specific RNA profiles, we felt that peripheral blood was an
appropriate medium to study to investigate celiac disease
associated genetic variants. Given the known genetic con-
tribution to disease, we enrolled treated celiac disease
individuals rather than healthy controls, leading to an
enrichment for celiac disease associated genetic variants
and underlying causal variants [20,28]. For 110 celiac dis-
ease samples that passed quality control, both expression
at 19,867 transcripts and genotype data for 257,013 SNPs,
were analyzed.
Gene expression in celiac disease versus healthy control 
samples
To obtain the most accurate reflection of mRNA levels in
peripheral blood leukocytes, whole blood RNA was
immediately fixed during venepuncture in PAXgene vials,
giving a reflection of in vivo RNA expression from whole
blood. One hundred and fifteen treated celiac patients, all
of whom were successfully treated and compliant with a
gluten free diet for at least six months, were enrolled. Sev-
enty percent of celiac disease patients were female,
(66.6% of adult cases diagnosed with celiac disease in the
population are female [29]). In addition, 22 random
healthy control samples were enrolled to obtain a back-
ground RNA expression profile, enabling us to determine
whether the patients indeed did not show ongoing
inflammation. In a sex matched comparison no known
inflammatory disease associated cytokines, including
IFNG [30] and IL2 [31] showed significantly increased
expression (sex matched Wilcoxon Signed-Ranks Test P
value < 0.05) in celiac versus control samples, as was
expected since these patients had been treated with a glu-
ten free diet.
Cis-associations of gene expression with SNPs
Gene expression levels for 19,867 transcripts were ana-
lyzed for significant genotypic effects at 257,013 auto-
somal SNPs, mapping within 500 kb of the centre of the
transcript probes, resulting in 1,850,599 tests. By using a
Spearman's rank correlation coefficient statistic and an
FDR of 0.01 or 0.05, 1,360 and 2,178 different SNP-probe
effects were detected, respectively. These reflect 394 and
658 unique probes, and 1,273 and 2,035 unique SNPs,
respectively (see Table 1).
An identical analysis was performed on publicly available
EBV-transformed B cell line expression and genotype data
for 90 CEU HapMap individuals [3]. Using this dataset
and a SNP-probe distance of 500 kb and FDR of 0.01 or
0.05, 1,799 and 2,839 different SNP-probe effects were
detected, respectively. These reflect 536 and 821 unique
probes, and 1,601 and 2,464 unique SNPs, respectively
(see Table 1). Details of all detected individual cis-eQTLs
are available in Additional file 1.
Distance between SNPs and probes that constitute the cis-
eQTLs
Our analysis was initially confined to probes that had a
midpoint distance to the tested SNPs less than 500 kb.
Analysis of the significant cis-eQTLs SNP-probe distances
(Figure 1) suggests few cis-eQTLs have been missed by
imposing this threshold, as in both datasets for 95% of
the cis-eQTLs, the SNPs map within 250 kb of the probes.
As such it is expected that an increase in statistical power
can be achieved by reducing the distance to 250 kb as less
tests will be performed. Indeed in the celiac peripheral
blood dataset more cis-eQTLs were identified (in total
2,487 different SNP-probe effects were observed, com-
pared to 2,178 in the 500 kb analysis, based on an FDR of
0.05), reflecting 765 unique probes and 2,315 unique
SNPs. For the HapMap B cell line dataset 3,226 different
SNP-probe effects were identified (compared to 2,839 in
the 500 kb analysis, based on an FDR of 0.05), reflecting
994 unique probes and 2,826 unique SNPs (see Table 1).
Subsequent analyses were confined to cis-eQTLs that had
been detected using this 250 kb window analysis.Page 4 of 13
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lines data sets
4,681 Illumina expression probes had oligonucleotide
sequences that are shared between the two different oligo-
nucleotide arrays used (Human Ref8 v2 & Human WG-1
v1). By limiting the analysis to a window size of 250 kb and
only to SNPs that had been successfully genotyped in both
studies, 576 different SNP-probe effects in the celiac
peripheral blood data at a FDR = 0.05 (338 at an FDR =
0.01) were detected. These reflect 573 different SNPs and
197 different probes. In the HapMap B cell line data, 573
different SNP-probe effects were identified at an FDR = 0.05
(290 at an FDR = 0.01), reflecting 573 different SNPs and
189 different probes. A combined meta-analysis of both
cohorts (weighted-Z method) identified 1,133 different
SNP-probe associations at an FDR = 0.05 (428 at an FDR =
0.01) (see Figure 2). These reflect 1,120 SNPs and 328
unique probes. 440 SNP-probe pairs, reflecting 217 differ-
ent probes and 439 different SNPs (FDR = 0.05) were not
detected when either dataset was analyzed separately.
135 identical SNP-Probe effects (reflecting 135 different
SNPs and 51 different probes) had been identified in both
the 110 celiac disease samples and in the 90 HapMap B
cell line samples (FDR = 0.05). In all cases, the combined
meta-P-Value for each of these shared cis-eQTLs was more
significant due to the larger sample size, indicating allelic
effects in the same direction. A comparison between cis-
eQTLs that had been detected in a large scale linkage
based genetical genomics study using RNA obtained from
peripheral blood mononuclear cells [2], and the cis-eQTLs
we detected, indicates that 57.3% (distance 250 kb,
0.05FDR) of probes, displaying a genotypic effect in the
celiac peripheral blood dataset, also show a linkage cis-
eQTL signal. Of note is that CCR3 and IL18RAP are both
identified as cis-eQTLs in both these datasets.
Primer Polymorphisms
While it can be assumed that for most of the detected cis-
eQTLs indeed the probe expression is affected by genetic
variation, it can also be that SNPs, mapping to regions to
which the probe hybridizes, may affect hybridization effi-
cacies and result in cis-eQTLs [32] that are not due to
expression differences. For the celiac peripheral blood
dataset, 10.0% of all Illumina HumanRef-8 v2 probes
map to regions that contain known dbSNP polymor-
phisms. For the HapMap B cell line dataset, 20.5% of all
Illumina HumanRef-6 v1 probes map to known SNPs. For
the probes that make up the identified cis-eQTLs (distance
250 kb, FDR = 0.05) this percentage is significantly higher
for both the celiac peripheral blood analysis (12,5%,
Fisher's Exact test P = 0.02) and even more pronounced
for the HapMap B cell line dataset (29.1%, P = 7.76 × 10-
11). Numbers within brackets in table 1 denote the
number of cis-eQTLs, probes or genes that are potentially
due to these primer polymorphisms. If these primer poly-
morphisms are responsible for different hybridization
efficacies, these SNPs should be in LD with the SNPs that
Table 1: Summary of cis-eQTL findings from celiac peripheral blood and HapMap B cell line data sets
Population 110 celiac disease samples
(Celiac peripheral blood dataset)
90 Caucasian HapMap samples
(HapMap B cell datasets)
Expression 
data
Illumina HumanRef-8 v2 Whole
Genome BeadChip (19,867 mapped transcripts)
Illumina HumanRef-6 v1 Whole
Genome BeadChip (44,791 mapped transcripts)
Genotype data Illumina Infinium HumanHap300 BeadChip 
(257,013 SNPs assessed)
Subset of all HapMap Genotypes present on Illumina Infinium 
HumanHap300 BeadChip (257,013 SNPs assessed)
FDR 0.01 FDR 0.05 FDR 0.01 FDR 0.05
SNP-Probe 
midpoint 
distance
250 kb 500 kb 250 kb 500 kb 250 kb 500 kb 250 kb 500 kb
FDR 
Spearman's 
Correlation P-
Value 
Threshold
p < 1.67 × 10-5 p < 6.57 × 10-6 p < 1.36 × 10-4 p < 5.47 × 10-5 p < 1.08 × 10-5 p < 4.20 × 10-6 p < 8.79 × 10-5 p < 3.47 × 10-5
Number of 
performed 
tests
930,456 1,850,599 930,456 1,850,599 1,913,342 3,820,148 1,913,342 3,820,148
Number of 
detected 
different
SNP-probe 
effects
1,529 (235) 1,360 (233) 2,487 (372) 2,178 (355) 1,981 (664) 1,799 (623) 3,226 (1,068) 2,839 (988)
Number of 
unique probes
470 (65) 394 (56) 765 (98) 658 (84) 613 (193) 536 (177) 994 (289) 821 (255)
Number of 
unique genes
460 (65) 385 (56) 753 (98) 647 (84) 563 (189) 491 (174) 903 (277) 746 (244)
Number of 
unique SNPs
1,432 (234) 1,273 (230) 2,315 (367) 2,035 (345) 1,743 (628) 1,601 (585) 2,826 (1009) 2,464 (920)
Numbers within brackets denote the number of cis-eQTLs, probes or genes that are potentially due to SNPs that map within the probe and affect the 
hybridization efficacies of these probes.Page 5 of 13
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eQTLs where genotype data was available within HapMap
Phase II for both the SNP that makes up the eQTL and for
the SNPs that map within the probe that constitutes this
particular eQTL. We compared the resulting distribution
of r2 values to a null distribution, generated by calculating
the LD between the SNP that makes up an eQTL and the
SNP that mapped immediately adjacent to the primer pol-
ymorphism SNP. While the mean LD (mean r2 = 0.27) in
the celiac peripheral blood was not significantly higher
than the mean LD in the null distribution (mean r2 = 0.25,
Wilcoxon Mann-Whitney P-Value = 0.86), this was
observed for the HapMap B cell line dataset (mean r2 =
0.46, mean r2 of null distribution = 0.30, Wilcoxon Mann-
Whitney P-Value = 6.3 × 10-8).
Differential gene expression between tissue sample types 
influences cis-eQTL detection
To enable a comparison of gene expression levels between
the HapMap B cell line samples and the celiac peripheral
blood samples, we limited our analysis to 12,401 tran-
scripts that map to identical exons. The expression levels
for these transcripts were quantile normalized. cis-eQTLs
that have only been significantly detected in the celiac
peripheral blood dataset, reflect probes that on average
show higher expression in the celiac peripheral blood
samples compared to HapMap B cell line samples (Wil-
coxon Signed-Ranks test, P = 7.6 × 10-7) (see Figure 3).
Conversely, probes that comprised HapMap B cell line
specific cis-eQTLs were higher expressed than within the
celiac peripheral blood dataset (P = 2.0 × 10-4). As
expected, probes that comprised cis-eQTLs that were com-
mon to both data sets did not show differences in expres-
sion (P = 0.30). Noteworthy is that IL18RAP and CCR3,
both recently identified as being genetically associated
with celiac disease [21], exhibited significant cis-regula-
tion in the celiac peripheral blood dataset but not in the
HapMap B cell line dataset. Cis-effects for these two genes
could be detected as these two genes showed markedly
upregulated expression in the celiac peripheral blood
dataset (expression rank order 12,072 vs. 6,431 and
11,104 vs. 3,602, respectively). These results indicate that
Cumulative genomic distance distribution between SNP and probe midpoint for significant cis-eQTLs (FDR = 0.01, SNP-probe midpoint dista ce < 500 kb) in celiac peripheral blood samplesFigure 1
Cumulative genomic distance distribution between SNP and probe midpoint for significant cis-eQTLs (FDR = 
0.01, SNP-probe midpoint distance < 500 kb) in celiac peripheral blood samples.Page 6 of 13
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insight in the potential functional consequences of dis-
ease associated genetic variants.
Overrepresented biological pathways
The genes, comprising the significant cis-eQTLs (distance
250 kb, FDR = 0.05), showed an overrepresentation of
hydrolase and transferase functions for both datasets, but
'immunity and defense' cis-eQTLs genes were more pre-
dominantly detected in the celiac disease peripheral
blood dataset than in the HapMap B cell line dataset (see
Additional file 2), as might be expected from the differen-
tial RNA profiles of the cells under investigation in each
dataset.
Significant opposite allelic directions for probes, mapping 
within the same genes
The observed concordance in allelic direction for the 135
significant SNP-probe effects, detected in both the 110
celiac peripheral blood and the 90 HapMap B cell line
samples was perfect when probe sequences were identical.
We also assessed whether the allelic directions for cis-
eQTLs probes was the same when multiple significant cis-
eQTL probes mapped within the same genes. We identi-
fied 14 genes (see Table 2) where this was not the case: sig-
nificant cis-eQTL probes with different oligonucleotide
sequences mapped to the same genes but showed oppo-
site allelic directions. For three of the genes, MRPL43,
OAS1 and TIPRL, we re-sequenced the probe regions in
four, four and three individuals with different genotypes,
respectively, and did not discover any polymorphisms,
confirming that these cis-eQTLs do not result from artifi-
cial hybridization differences.
Identification of trans effects and conditioned co-
expression analysis
We used the celiac disease dataset to assess whether signif-
icant trans-eQTLs could be identified (Spearman's rank
Summary of meta-analysis of 4,681 identical probes between the celiac peripheral blood and HapMap B cell line data sets (at an FDR = 0.05, SNP-probe midpoint distance < 250 kb)igure 2
Summary of meta-analysis of 4,681 identical probes between the celiac peripheral blood and HapMap B cell 
line data sets (at an FDR = 0.05, SNP-probe midpoint distance < 250 kb).Page 7 of 13
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trans-eQTLs were detected: rs2318331 (mapping within
COL22A1) with GI_48093066 (NBPF3) and rs12634559
(mapping downstream of IL1RAP) with GI_16306505
(CASP8AP2). However, these trans-eQTLs were not
detected in the HapMap B cell line dataset, even after
relaxing the nominal Spearman rank correlation P-value
to 0.05.
As trans-eQTLs implicate (direct or indirect) biological
relationships, it is somewhat disappointing that none
were clearly identified. An alternative way to identify bio-
logical relationships is by using co-expression analysis
(although such an analysis does not have the aim to iden-
tify or explain trans-eQTLs). We conducted such a co-
expression analysis and compared it to a co-expression
analysis that also takes the genetic variation into account.
First, co-expression was assessed between each of the
probes that constitute cis-eQTLs (SNP-probe midpoint
distance < 250 kb, FDR = 0.05) and all other probes (Fig-
ure 4a) that do not map to the same chromosome, by cal-
culating all pair-wise Spearman correlation coefficients.
This resulted in 13,003,505 and 42,270,807 pair-wise
tests for the celiac peripheral blood dataset (using 765 dif-
ferent cis-probes) and the HapMap B cell line dataset
(using 994 different cis-probes), respectively. Through
Bonferroni correction we accounted for multiple testing,
resulting in the identification of 50,821 and 168,292 sig-
nificantly correlated transcript-pairs respectively (Spear-
man's correlation test P-Value < 0.05 after multiple testing
correction).
Subsequently, we redid this co-expression analysis after
having removed the genotypic effect on the probe inten-
sity level for the probes that constitute the significant cis-
eQTLs (Figure 4b). We observed a considerably increased
number of significantly correlated transcript-pairs: 54,773
(an increase of 7.8%) and 258,874 (an increase of
53.8%), respectively.
To validate whether this increase in co-expressed tran-
scripts reflects known biology, we assessed a collection
of 80,350 known biological interactions (derived on 17
April 2007 from KEGG [33], BioGrid [34], Reactome
[35], BIND [36], HPRD [37] and IntAct [38]). For the
celiac peripheral blood dataset 91 of the 50,821
(0.179%) significantly correlated transcript-pairs that
had been identified in the unconditioned co-expression
analysis are known to interact. In the conditioned co-
expression analysis 106 of the 54,773 (0.194%) tran-
script pairs were known to interact, indicating an 8.0%
increase in the proportion of known biological interac-
tions that was identified. Comparable results were
obtained for the HapMap B cell line dataset: For the
unconditioned co-expression analysis 334 of the
168,292 (0.195%) significant transcript-pairs are known
to interact. In the conditioned co-expression analysis
634 of the 258.874 (0.245%) significant transcript-pairs
are known to biologically interact, representing an
increase of 23.4% in the proportion of known interac-
tions among the most significantly co-expressed tran-
script-pairs.
Differential Gene Expression between tissue types results in differential cis-eQTL detection Differential gene expression between the celiac data et and the HapMap dataset is represent d as  hi togram of log f ld changeFigu  3
Differential Gene Expression between tissue types results in differential cis-eQTL detection Differential gene 
expression between the celiac dataset and the HapMap dataset is represented as a histogram of log fold 
change. a) Density plot of log fold change for cis-eQTLs detected in celiac dataset but not in HapMap samples (FDR = 0.01, 
SNP-probe midpoint distance < 250 kb). b) Density plot of log fold change for cis-eQTLs detected in HapMap dataset but not 
in the celiac dataset, c) Density plot of log fold change for cis-eQTLs detected in both data sets. P values derived from a Wil-
coxon Signed-Ranks Test.Page 8 of 13
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Table 2: Genes containing multiple probes that are affected by SNPs that also affect other probes in the same gene, but with opposite 
allelic directions
Source SNP HUGO Spearman Probe Unique Illumina 
Identifier*
Probe Sequence Number of dbSNP 
polymorphisms known 
within probe region
Celiac rs1131383 POLR2J -0.48 GI_62422568 ILMN_1657317 0
HapMap rs1131383 POLR2J 0.57 GI_21704275 4210731 0
Celiac rs1901198 IRF5 -0.6 GI_38683857 ILMN_1670576 0
HapMap rs1901198 IRF5 0.5 GI_38683858 1770358 0
Celiac rs6565724 LOC400566 0.67 GI_62177143 ILMN_1713803 0
HapMap rs6565724 LOC400566 -0.72 GI_37544593 6040008 0
HapMap rs6565724 LOC400566 -0.74 GI_42661283 103170403 0
Celiac rs2863095 MRPL43 0.45 GI_28872731 ILMN_1652147 0
Celiac rs2863095 MRPL43 -0.49 GI_28872733 ILMN_1700477 0
HapMap rs2863095 MRPL43 0.58 GI_28872731 3940465 0
HapMap rs2863095 MRPL43 -0.61 GI_28872733 5900487 0
HapMap rs4768933 DIP2B 0.42 GI_17457388 101780735 0
HapMap rs4768933 DIP2B -0.44 GI_39930390 3940278 0
Celiac rs10774679 OAS1 -0.54 GI_74229010 ILMN_1658247 0
Celiac rs10774679 OAS1 0.51 GI_74229012 ILMN_1672606 0
HapMap rs3177979 OAS1 0.63 GI_8051620 2100154 0
HapMap rs3177979 OAS1 -0.72 GI_8051622 2100048 0
Celiac rs1040404 TIPRL -0.47 GI_73088904 ILMN_1779432 0
Celiac rs1040404 TIPRL 0.5 GI_73088933 ILMN_1781457 0
HapMap rs222851 C17orf81 -0.72 GI_44662825 6380129 0
HapMap rs222851 C17orf81 0.64 GI_44662829 2760301 0
Celiac rs34374 PAM 0.43 GI_21070979 ILMN_1788631 GGCTACAGTCGAAAA
GGGTTTGACCGGCTT
AGCACTGAGGGCAG
TGACCA
0
HapMap rs34374 PAM -0.41 GI_21070979 60056 GCCAGTGTCTTTCTT
TGGTGCCTTTCCTGT
TCAGCATTCTTAGCC
TGTGG
0
HapMap rs2838859 POFUT2 -0.48 GI_34147486 5900341 1
HapMap rs2838859 POFUT2 0.45 Hs.300736 106110059 0
Celiac rs7084722 PTER -0.43 GI_47933342 ILMN_1795336 0
HapMap rs7084722 PTER 0.48 GI_20070185 5570040 1
Celiac rs10503170 MYOM2 0.43 GI_4505314 ILMN_1716733 ATTTTCACGGGTGTG
GGCACATGGGTGTG
GCACCTGGACGTGT
GCAGCAT
1
HapMap rs10503170 MYOM2 -0.42 GI_4505314 6620154 TTTACACGAGGGTAG
ACGGCAGATGCCTG
ACAGAGAGTGGGTT
GGCAGAC
1
Celiac rs11680305 ADI1 -0.42 GI_8922761 ILMN_1795671 CCGGTGGTGTGATG
ATGCCATATACCGCA
GGGCTTGCTTCTGTC
AAGTGT
1
HapMap rs11680305 ADI1 0.41 GI_8922761 4730070 GAGCTCCCACCCTA
AGGGGCACACACTG
AGTTGCTTATGCCAC
TTCCTTG
0
Celiac rs2395185 HLA-DRB5 -0.41 GI_26665892 ILMN_1697499 GGCTCTTATTCTTCC
ACAAGAGAGGACTTT
CTCAGGCCCTGGTT
GCTACC
3
HapMap rs2395185 HLA-DRB5 0.47 GI_26665892 450332 ACGGCCTCCCATGC
ATCTGTACTCCCCCT
GTGTGCCACAAATGC
ACTACG
8
Meta-analysis of different significant but opposite allelic effects of SNPs (FDR = 0.05, SNP-probe midpoint distance < 250 kb) in the celiac peripheral 
blood dataset and HapMap B cell line data set. Shown are 14 genes that contain probes for either of the two platforms but that show opposite allelic 
directions. If probes have identical identifiers on the two platforms, but different oligonucleotide sequences, the oligonucleotide sequences are indicated.
*As provided by Illumina platform record.
BMC Medical Genomics 2009, 2:1 http://www.biomedcentral.com/1755-8794/2/1Figure 4c provides an example for Ubiquitin (UBA52), for
which a strong cis-eQTL was observed for probe
GI_15451941 with rs2314664 (Spearman's correlation
coefficient P-Value = 1.11 × 10-16) in the HapMap B cell
line dataset. Within this probe three other polymorphism
map (rs6554, rs34040670 and rs3209501), of which
rs6554 is in near perfect LD with rs2314664 (r2 = 0.98,
HapMap CEU population), suggesting this cis-eQTL does
not reflect a real expression difference, but rather a differ-
ence in hybridization efficacy. Co-expression with other
genes is already present in an unconditioned co-expres-
sion analysis, because the distribution of co-expression
for UBA52 with all other genes differs significantly from a
theoretical null-distribution (Wilcoxon-Mann Whitney P-
Value < 1 × 10-12). However, in the conditioned co-expres-
sion analysis, this difference is more pronounced (see fig-
ure 4c). When confining this analysis to a set of 156
known interactions for UBA52, overall co-expression was
significantly stronger for these pairs of genes in the condi-
tioned (mean absolute Spearman's correlation coefficient
= 0.39) than in the unconditioned co-expression analysis
(mean absolute Spearman's correlation coefficient = 0.20,
Wilcoxon-Mann Whitney P-Value < 10-50).
Discussion
We have demonstrated the use of peripheral blood RNA
samples for the detection of cis-eQTLs and have shown
that there is strong allelic concordance with cis-eQTLs that
also had been detected in a HapMap B cell line dataset.
These results indicate that a meta-analysis with larger sam-
ple size and hence statistical power results in a considera-
ble increase in the detected cis-eQTL even though the
arrays that had been used were different. Some cis-eQTLs
can be observed across multiple tissue types, in all cases in
the same allelic direction, suggesting a major conserved
function. However most of the detected cis-eQTLs in these
datasets were only detected in one of the two tissues, sug-
gesting that more insight can be gained in the functional
consequences of genetic variation by performing genetical
genomics studies using different types of cells and tissues.
This point is particularly relevant for identifying the func-
tion of risk variants for common diseases: for example
study immune tissues for immune-mediated diseases, adi-
pose tissue for obesity traits [8], brain tissue for neurolog-
ical traits [10]. Genetical genomics experiments
performed in outbred human populations are addition-
ally complex and in addition to tissue specific RNA pro-
files, care should be taken to investigate alternative RNA
sequence events, primer polymorphisms that generate
false eQTLs and strong cis-eQTLs that obscure weaker trans
effects.
It is attractive to assume most of the observed cis-eQTLs
reflect overall gene expression level alterations. However,
we did observe 14 genes (Table 2) where different probes
showed significant opposite allelic effects. For at least five
out of the 14 genes (POFUT2, PTER, MYOM2, ADI1 and
HLA-DRB5) polymorphisms within the probe are known
to exist in dbSNP. For each of these genes, it may be that
one cis-eQTL for instance reflects a real expression differ-
ence, whereas the other reflects a hybridization effect due
to the presence of these SNPs within the probe. However,
recently Kwan et al [39] provided another potential expla-
nation, as they showed for three of the 14 genes (IRF5,
MRPL43 and PTER), using Affymetrix GeneChip Human
Exon 1.0 ST Arrays, that different genetic variants can
result in premature 3' termination events. The SNPs that
make up these cis-eQTLs are all in strong linkage disequi-
librium with the SNPs Kwan et al described (IRF5:
rs7808907 and rs6969930: D' = 1, R2 = 0.74 rs2863095,
MRPL43: rs2863095 and rs12241232: D' = 0.89, R2 =
0.75, PTER: rs7909832 and rs1055340: D' = 1, R2 = 1),
supporting our observations. Kwan et al examined differ-
ent exonic effects through an independent validation
using quantitative RT-PCR (out of a total of 25 validated
genes) and estimated that only 39% of the detected cis-
eQTLs influence overall gene expression levels. For the
remaining cis-eQTLs genetic variation results in prelimi-
nary terminated transcripts (18%), not initiated tran-
scripts (11%), transcripts that are spliced differentially
(26%) or a combination of these (6%). We acknowledge
that our use of oligonucleotide arrays, predominantly tar-
geting the 3' end of genes, gives a more limited picture of
splicing since only 3' termination events can be seen.
However, the data presented above and alluded to by
Kwan et al [39] suggest that SNP genotypes can have a sig-
nificant effect on alternatively spliced transcript isoforms.
This additional layer of complexity should be examined in
future genetical genomics experiments to fully elucidate
the genotypic effects on RNA.
Although the two trans-effects identified (IL1RAP and
CASP8AP2) are interestingly both involved in an apopto-
sis pathway, these trans-eQTLs were not detected in the
HapMap B cell line dataset. These trans-eQTL results are in
strong contrast to the number of cis-eQTLs we detected
within the two data sets. This results primarily from the
limited statistical power to detect trans-eQTLs, due to the
number of statistical tests that need to be performed.
Additionally, in order to cause a trans-effect, more inter-
mediate biological steps are required that introduces addi-
tional biological noise, lessening the correlation between
genotype and trans-gene expression. Cis-eQTLs can have a
significant impact on the co-expression of genes; this gen-
otypic variation may hinder the identification of signifi-
cant trans effects. This adds an additional layer of
complexity to the analysis of genotypic effects on gene
expression in outbred populations.
As it has been one of the goals of genetical genomics to
identify biological relationships we suggest that the con-
ditioned co-expression analysis we carried out here, mightPage 10 of 13
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Cis-effects obscure detection of co-expression with other genes a) Co-expression for significant cis-eQTLs was determined; resulting in the id ntification of co-expression pa rs with generally low absolute correlation oeffi ients b) Through re oval of the ge otypic effect on the cis-eQTL obe, for some cis-eQTL  strong co-expressi n ca  be mor  asily detectedF g r  4
Cis-effects obscure detection of co-expression with other genes a) Co-expression for significant cis-eQTLs was 
determined; resulting in the identification of co-expression pairs with generally low absolute correlation coeffi-
cients b) Through removal of the genotypic effect on the cis-eQTL probe, for some cis-eQTLs strong co-
expression can be more easily detected. c) An example for UBA52 indicates that a conditioned co-expression analysis can 
help to identify meaningful biological relationships: Within the conditioned co-expression distribution (indicated in dark blue) 
there are more strongly co-expressed genes, opposed to an unconditioned analysis (indicated in red). This is supported by an 
analysis of 156 known interacting genes for UBA52: In the conditioned co-expression analysis (indicated in light blue) co-
expression is generally much stronger than in the unconditioned analysis (indicated in yellow).
BMC Medical Genomics 2009, 2:1 http://www.biomedcentral.com/1755-8794/2/1help to uncover these: We have shown that more known
biological relationships can be identified when using
genetical genomics to perform co-expression analyses that
have been conditioned on genotype. An explanation for
this observation is that cis-eQTLs sometimes convolute
co-expression, as is exemplified for UBA52, where primer
polymorphisms probably affect hybridization characteris-
tics.
Conclusion
This study shows that PAXgene isolated peripheral blood
RNA is a powerful resource for investigating functional
consequences of genetic variation. We have shown that
for some of the cis-eQTLs the functional consequences are
more complex than previously assumed. Additionally,
these findings imply that biological relationships can be
extracted in outbred populations, although in a somewhat
different manner than what is commonly used to detect
biological relationships through trans-eQTLs in inbred
model organisms.
As this study has only combined genetics with genomics,
we envision more extensive integrative approaches, incor-
porating e.g. epigenetics and proteomics, will help to
improve the detection of previously unknown biological
pathways.
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